Key result
Review summarizes interactions between hypertension treatments and rheumatic diseases like rheumatoid arthritis, osteoarthritis, and gout.
This article reviews the interactions between rheumatic diseases (such as rheumatoid arthritis, osteoarthritis, and gout) and the treatment of hypertension.
Answers are grounded in this paper and cite their sources.
May inform comorbidity-aware BP management; leaves open dedicated trials to guide integrated care in rheumatic disease.
Introduction Among “rheumatic” diseases rheumatoid arthritis (RA) is the most common immune-inflammatory disorder characterized by symmetric polyarthritis affecting predominantly the small joints of the hands and feet. In patients with seropositive RA, the disease course is more aggressive, extra-articular manifestations are more frequent and their mortality is increased. Osteoarthritis (OA) is one of the most common causes of disability in adults. It is caused by chronic damage of the cartilage in joints large ones are most frequently involved. Beyond them, gout deserves special attention since it has multiple interactions with hypertension or its treatment.
No takes yet. Share an insight, caveat, or question.
A 2013 study conducted a review in Hypertension in patients with rheumatic diseases. Treatment of hypertension was evaluated. This review discusses the interactions between hypertension or its treatment and rheumatic diseases such as rheumatoid arthritis, osteoarthritis, and gout.
Synapse has enriched 10 related papers. Consider them for comparative context: